⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for primary drug resistance of oxitinib

Every month we try and update this database with for primary drug resistance of oxitinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLCNCT06436144
Non Small Cell ...
EGFR Gene Mutat...
Non Small Cell ...
Non-small Cell ...
Osimertinib
18 Years - 80 YearsDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLCNCT06436144
Non Small Cell ...
EGFR Gene Mutat...
Non Small Cell ...
Non-small Cell ...
Osimertinib
18 Years - 80 YearsDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: